POINT Biopharma Statements
PN
Data from POINT Biopharma`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
30 Sep, 2023
Next reporting period:
29 Dec, 2023
Report frequency:
Quarterly
Earnings release date:
—
Expected release date:
—
POINT Biopharma Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2.8
-42.9 %
100
—
0
—
—
0
26.9
960.7
5.5
196.4
32.4
-11 %
1157.1
-29.6
6 %
-1057.1
5.7
203.6
—
0
-23.9
9.1 %
-853.6
0.9
32.1
-24.8
2.4 %
-885.7
-0.23
105.8
4.9
-48.4 %
100
—
0
—
—
0
31.3
638.8
5.1
104.1
36.4
14.1 %
742.9
-31.5
-40 %
-642.9
5.2
106.1
—
0
-26.3
-56.5 %
-536.7
-0.9
-18.4
-25.4
-53.9 %
-518.4
-0.24
105.7
9.5
-95.8 %
100
—
0
—
—
0
26.9
283.2
5
52.6
31.9
-9.4 %
335.8
-22.5
-111.8 %
-236.8
5.7
60
—
0
-16.8
-108.7 %
-176.8
-0.2
-2.1
-16.5
-110.1 %
-173.7
-0.16
105.7
226.6
—
100
—
0
—
—
0
27.9
12.3
7.3
3.2
35.2
43.1 %
15.5
191.4
878 %
84.5
2.7
1.2
—
0
194.1
915.5 %
85.7
30.8
13.6
163.3
780.4 %
72.1
1.46
111.5
—
—
100
—
0
—
—
0
20.8
0
3.8
0
24.6
-1.2 %
0
-24.6
1.2 %
0
0.8
0
—
0
-23.8
2.5 %
0
0.2
0
-24
2.4 %
0
-0.26
92.4
—
—
100
—
0
—
—
0
20.8
0
4.1
0
24.9
52.8 %
0
-24.9
-52.8 %
0
0.5
0
—
0
-24.4
-49.7 %
0
0.2
0
-24.6
-50 %
0
-0.27
90.1
—
—
100
—
0
—
—
0
12.5
0
3.8
0
16.3
15.6 %
0
-16.3
-15.6 %
0
—
0
—
0
-16.3
-15.6 %
0
0.1
0
-16.4
-15.5 %
0
-0.18
90.1
—
—
100
—
0
—
—
0
9.5
0
4.6
0
14.1
-17.1 %
0
-14.1
17.1 %
0
—
0
—
0
-14.1
17.1 %
0
0.1
0
-14.2
17 %
0
-0.16
90.5
—
—
100
—
0
—
—
0
13
0
4
0
17
95.4 %
0
-17
-95.4 %
0
—
0
—
0
-17
-95.4 %
0
0.1
0
-17.1
-94.3 %
0
-0.19
90.1
—
—
100
—
0
—
—
0
6.7
0
1.9
0
8.7
52.6 %
0
-8.7
-52.6 %
0
—
0
—
0
-8.7
-52.6 %
0
0.1
0
-8.8
-51.7 %
0
-0.1
90.1
—
—
100
—
0
—
—
0
4.3
0
1.5
0
5.7
-56.5 %
0
-5.7
56.5 %
0
—
0
—
0
-5.7
57.1 %
0
—
0
-5.8
56.6 %
0
-0.06
90.1
—
—
100
—
0
—
—
0
—
0
3.973
0
13.115
7692.1 %
0
-13.115
-7692.1 %
0
-0.17
0
—
0
-13.285
-7935 %
0
0.088
0
-13.373
-7988.2 %
0
-0.148
90.122
—
—
100
—
0
—
—
0
—
0
—
0
0.168
-94.7 %
0
-0.168
94.7 %
0
0.003
0
—
0
-0.165
94.7 %
0
—
0
-0.165
94.8 %
0
-0.01
17.383
—
—
100
—
0
—
—
0
2.2
0
1.1
0
3.2
128.6 %
0
-3.2
-128.6 %
0
0.1
0
—
0
-3.1
-93.8 %
0
0.1
0
-3.2
-100 %
0
-0.04
90.1
—
—
100
—
0
—
—
0
0.4
0
1
0
1.4
—
0
-1.4
—
0
-0.2
0
—
0
-1.6
—
0
—
0
-1.6
—
0
-0.02
90.1